Skip to main
PACS

PACS Stock Forecast & Price Target

PACS Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 60%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PACS Group is a leading provider of skilled nursing facilities, with a sizable and growing footprint and attractive clinical capabilities. The company has a strong financial outlook, with projected adjusted EBITDA of $555-$575M in 2026. With a decentralized model and focus on underperforming facilities, PACS has the potential for significant growth in the fragmented post-acute care market.

Bears say

PACS Group is facing operational challenges and reporting delays due to an internal investigation, which may impact its ability to gain momentum and execute its M&A strategy in the near term. The company's leverage position is relatively low, but may not be enough to support its M&A strategy if it continues to face hurdles. Despite a robust M&A pipeline, there are uncertainties surrounding the timing and success of potential deals, leading to a negative outlook on the stock.

PACS has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 60% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PACS Group, Inc. and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PACS Group, Inc. (PACS) Forecast

Analysts have given PACS a Buy based on their latest research and market trends.

According to 5 analysts, PACS has a Buy consensus rating as of Aug 27, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $56, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $56, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PACS Group, Inc. (PACS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.